The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
SHC · Healthcare · Shallow moat
Doesn't clear the bar
The balanceSheet component abstained: Insufficient leverage/coverage inputs to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.
VXRT · Healthcare · Shallow moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | SHC | VXRT | PODD | COO |
|---|---|---|---|---|
| Moat Score (0–100) | 54 (highest) | 54 (highest) | 54 (highest) | 54 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 69 | 67 | 78 | 88 (highest) |
| Pricing power | 92 | — | 94 | 100 (highest) |
| Returns on capital | 12 (highest) | 6 | 11 | 0 |
| Balance-sheet safety | — | 100 (highest) | 64 | 36 |
| Capital discipline | 44 | 44 | 24 | 46 (highest) |
| Price vs. high estimate | No price data | No price data | 217% above high estimate | 99% above high estimate (largest discount to high estimate) |
| Market cap | — | $120.2M | $11.8B | $14.0B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |